The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Lipodystrophy Syndromes — Endocrine Effects

Metabolic disorders with loss or abnormal distribution of adipose tissue.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Internal Medicine department. Book Appointment →

What is Lipodystrophy Syndromes — Endocrine Effects?

Lipodystrophy syndromes are a heterogeneous group of disorders in which subcutaneous adipose tissue is partially (partial) or completely (generalized) lost due to genetic or acquired causes. Adipose loss leads to ectopic lipid deposition and metabolic complications.

Congenital generalized lipodystrophy (Berardinelli-Seip syndrome) and familial partial lipodystrophy (Dunnigan syndrome) are the best-known genetic forms. Among acquired forms, HIV-associated lipodystrophy (antiretroviral therapy) is most common.

Leptin deficiency is one of the core metabolic mechanisms; metreleptin (recombinant leptin) therapy is FDA-approved in generalized lipodystrophy.

Symptoms

Marked subcutaneous fat loss (generalized or regional)
Prominent muscle definition and superficial veins
Acanthosis nigricans (severe insulin resistance)
Hepatomegaly (hepatic steatosis)
Eruptive xanthomas (severe hypertriglyceridemia)
PCOS-like findings (in women)

Risk Factors

Genetic mutations (AGPAT2, BSCL2, LMNA, PPARG, PLIN1)
HIV infection and antiretroviral therapy (protease inhibitors, NRTI)
Autoimmune diseases (acquired generalized lipodystrophy)
Repeated injection-site trauma

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Marked subcutaneous fat loss + severe metabolic disturbance (DM, hypertriglyceridemia)
  • If body composition changes occur during HIV therapy
  • Generalized fat loss + early diabetes in childhood
  • Triglyceride >500 mg/dL (pancreatitis risk) → URGENT

Treatment Methods

01
Metreleptin (recombinant leptin — FDA-approved in generalized lipodystrophy)
02
Insulin sensitizers (metformin, thiazolidinediones — partial forms)
03
High-dose insulin therapy (in severe insulin resistance)
04
Fibrates or omega-3 (hypertriglyceridemia management)
05
ART regimen change in HIV lipodystrophy (tesamorelin — abdominal fat reduction)
06
Cosmetic approaches (fat grafting — for facial lipodystrophy)

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Lipodystrophy Syndromes

Endokrinoloji

Lipodystrophies are rare metabolic disorders in which genetic or acquired loss of subcutaneous fat causes insulin resistance, dyslipidemia, fatty liver, and diabetes.

Thyroid Nodule Evaluation

Endokrinoloji

Thyroid nodules are very common and the vast majority are benign; however, fine-needle aspiration biopsy may be required based on ultrasound features for malignancy risk assessment.

Management of Graves' Disease

Endokrinoloji

Graves' disease is the most common cause of autoimmune hyperthyroidism, developing with excessive stimulation of the thyroid gland by thyroid-stimulating antibody (TRAb).

Management of Hashimoto's Thyroiditis

Endokrinoloji

Hashimoto's thyroiditis is the most common cause of hypothyroidism, due to autoimmune destruction of the thyroid gland with anti-TPO and anti-thyroglobulin antibodies.

Primary Adrenal Insufficiency (Addison's Disease)

Endokrinoloji

Addison's disease is a potentially life-threatening endocrine disorder presenting with cortisol and aldosterone deficiency due to autoimmune destruction of the adrenal glands.

Cushing Syndrome Diagnostic Workup

Endokrinoloji

Cushing syndrome is an endocrine disorder presenting with central obesity, striae, hypertension, and metabolic disturbances due to chronic glucocorticoid excess; its diagnosis is challenging.

Pheochromocytoma and Paraganglioma

Endokrinoloji

Pheochromocytomas and paragangliomas are rare tumors that secrete excess catecholamines, causing paroxysmal hypertension, headache, sweating, and palpitations.

Primary Hyperaldosteronism (Conn Syndrome)

Endokrinoloji

Primary hyperaldosteronism is a treatable cause of resistant hypertension and hypokalemia caused by excessive aldosterone secretion from the adrenal gland.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.